好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Clinical and Electrophysiological Evaluation of Patients with Thymic Pathology in Terms of Myasthenia Gravis
Neuromuscular and Clinical Neurophysiology (EMG)
P9 - Poster Session 9 (8:00 AM-9:00 AM)
11-019

Myasthenia Gravis (MG) is an autoimmune disease known to be often associated with thymic pathologies. This study aimed to evaluate the clinical, serological and electrophysiological data of patients with thymic pathology in terms of possible accompanying MG.

MG is an autoimmune disease known to be often associated with thymic pathologies. This study aimed to evaluate the clinical, serological and electrophysiological data of patients with thymic pathology in terms of possible accompanying MG.

In our study, patients who were consulted to the neurology unit by the thoracic surgery unit in 2021-2022 for possible accompanying MG due to diagnoses of thymic hyperplasia or thymoma were evaluated. Clinical findings of the patients, acetylcholine receptor antibody(AChR-ab) levels and electrophysiological data of repetitive nerve stimulation(RNS) and single fiber electromyography(SFEMG) examinations performed with concentric needle electrode(CNE) were examined.

  • No significant incremental response was observed in RNS in any of the 33(13 female, 20 male) patients. In SFEMG performed with CNE, the mean jitter(MJ) increased in 12.1% of the patients. There were MG-related findings in the clinical examination of all patients with increased MJ. AChR-ab was positive in only 1 patient. The pathologies of those who were operated on(63.6%) were thymoma in 42.8%, thymic hyperplasia in 33.3%, thymic cyst in 9.5%, thymic remnant in 9.5%, diffuse large B-cell lymphoma in 4.7%, typical carcinoid tumor in 4.7% and adenomatous nodule in 4.7%. Although no significant relationship was observed between pathological subtypes and electrophysiological findings, the patient with the highest mean jitter value had diffuse large B-cell lymphoma.

This study has shown that in patients consulted with thymic pathologies and neurological clinics, in the absence of clinical symptoms related to MG, serological and electrophysiological tests may increase the diagnostic burden. Furthermore, if there are clinical suspicions, relying solely on RNS evaluations is not sufficient; SFEMG test is necessary.

Authors/Disclosures
Beyza A. Arslan, MD
PRESENTER
Dr. Arslan has nothing to disclose.
Pinar Kahraman Koytak, MD Dr. Kahraman Koytak has nothing to disclose.
Kayihan Uluc, MD (Marmara Universitesi Pendik EAH) Dr. Uluc has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.